Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Stefan

Showing results (61-70 of 302) with videos related to

Pageof 31
Sort By:
Nature Communications|February 19, 2026
Preclinical and clinical obesity: prevalence, associations to cardiometabolic risk and response to lifestyle intervention in NHANES and the EPIC-Potsdam and TULIP studiesCatarina Schiborn, Frank B Hu, Norbert Stefan, et al.
Atherosclerosis|March 22, 2005
Reduced adiponectin serum levels in smokersClaus Thamer, Norbert Stefan, Michael Stumvoll, et al.
Diabetes Care|September 1, 2009
High baseline vitamin C levels do not prevent a positive outcome of a lifestyle interventionClaus Thamer, Fausto Machicao, Norbert Stefan, et al.
Diabetologia|September 11, 2019
Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factorsClemens Wittenbecher, Olga Kuxhaus, Heiner Boeing, et al.
JAMA Network Open|May 7, 2021
An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total MortalityAnika Zembic, Nathalie Eckel, Norbert Stefan, et al.
Nature Reviews. Endocrinology|April 25, 2020
Obesity and impaired metabolic health in patients with COVID-19Norbert Stefan, Andreas L Birkenfeld, Matthias B Schulze, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implicationsNorbert Stefan, Hans-Ulrich Häring, Frank B Hu, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 14, 2006
Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetesPeter Weyrich, Norbert Stefan, Hans-Ulrich Häring, et al.
Cardiovascular Diabetology|January 9, 2022
Fetuin-A and risk of diabetes-related vascular complications: a prospective studyAnna Birukov, Elli Polemiti, Susanne Jäger, et al.
Diabetes Care|January 31, 2006
The -8503 G/A polymorphism of the adiponectin receptor 1 gene is associated with insulin sensitivity dependent on adiposityKonstantinos Kantartzis, Andreas Fritsche, Fausto Machicao, et al.
Pageof 31

Showing results (61-70 of 302) with videos related to

Sort By:
Pageof 31
Nature Communications|February 19, 2026
Preclinical and clinical obesity: prevalence, associations to cardiometabolic risk and response to lifestyle intervention in NHANES and the EPIC-Potsdam and TULIP studiesCatarina Schiborn, Frank B Hu, Norbert Stefan, et al.
Atherosclerosis|March 22, 2005
Reduced adiponectin serum levels in smokersClaus Thamer, Norbert Stefan, Michael Stumvoll, et al.
Diabetes Care|September 1, 2009
High baseline vitamin C levels do not prevent a positive outcome of a lifestyle interventionClaus Thamer, Fausto Machicao, Norbert Stefan, et al.
Diabetologia|September 11, 2019
Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factorsClemens Wittenbecher, Olga Kuxhaus, Heiner Boeing, et al.
JAMA Network Open|May 7, 2021
An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total MortalityAnika Zembic, Nathalie Eckel, Norbert Stefan, et al.
Nature Reviews. Endocrinology|April 25, 2020
Obesity and impaired metabolic health in patients with COVID-19Norbert Stefan, Andreas L Birkenfeld, Matthias B Schulze, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implicationsNorbert Stefan, Hans-Ulrich Häring, Frank B Hu, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 14, 2006
Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetesPeter Weyrich, Norbert Stefan, Hans-Ulrich Häring, et al.
Cardiovascular Diabetology|January 9, 2022
Fetuin-A and risk of diabetes-related vascular complications: a prospective studyAnna Birukov, Elli Polemiti, Susanne Jäger, et al.
Diabetes Care|January 31, 2006
The -8503 G/A polymorphism of the adiponectin receptor 1 gene is associated with insulin sensitivity dependent on adiposityKonstantinos Kantartzis, Andreas Fritsche, Fausto Machicao, et al.
Pageof 31